<DOC>
	<DOCNO>NCT01286324</DOCNO>
	<brief_summary>The purpose study determine herb call chamomile help treat insomnia ( difficulty go sleep get enough sleep ) increase amount time sleep and/or improve quality sleep . The study also look effect chamomile day time fatigue functioning .</brief_summary>
	<brief_title>Chamomile Chronic Primary Insomnia</brief_title>
	<detailed_description>Insomnia , define inability initiate maintain sleep lack restorative sleep , prevalent sleep complaint primary care . Insomnia associate decrease quality life , work limitation increase healthcare utilization . Currently treatment chronic insomnia readily available , affordable , without significant side-effects demonstrate safe long term use . Consequently , treatment would fill gap need . Chamomile ( Matricaria recutita ) use gentle sleep agent herbalist several hundred year . It study animal sedative potential show promise treat insomnia . Currently , chamomile 's sedative mechanism action unknown , think major inhibitory neurotransmitter central nervous system , γ - aminobutyric acid ( GABA ) . However , study examine chamomile 's efficacy safety treat insomnia . The investigator propose double-blind , placebo-controlled , randomized trial chamomile primary care patient chronic insomnia . Thirty-four patient randomize either Chamomile High Grade Extract , three 5 mg tablet standardize 0.4 % ( - ) -α-bisabolol twice daily placebo follow 28 day change sleep diary ( sleep efficiency , total sleep time , sleep-onset latency sleep quality ) , insomnia severity sleep disturbance . Secondary endpoint include assessing change day time function ( measure global quality life , depression anxiety ) monitoring sign toxicity . The investigator also determine feasibility conduct large trial agent .</detailed_description>
	<mesh_term>Sleep Initiation Maintenance Disorders</mesh_term>
	<criteria>Men woman age 18 64 year ; Must able give write informed consent ; Have diagnosis primary insomnia per DSMIV criterion , report &lt; 6.5 hour sleep and/or &gt; 30 minute fall asleep ( SOL ) and/or wake sleep onset ( WASO ) &gt; 30 minute , three night per week ; Present sleep complaint least 6 month ; Women pregnant , lactate less six month postpartum . Due fact assessment reproductive performance teratology test conduct exclude pregnant lactating woman ; Patients unstable medical condition ; DSMIV Axis I personality disorder diagnosis exception patient treat stable unipolar depression generalize anxiety disorder ( PRIMEMD score within normal range disorder ) ; Difficulty sleep initiation maintenance associate know medical diagnosis condition may affect sleep , e.g. , sleep apnea , restless leg syndrome , chronic pain ; Evidence lack reliability noncompliance define miss pretreatment appointment twice ; Current diagnosis substance abuse dependence ; Known allergy chamomile member ragweed family ; Currently take cyclosporine , warfarin chronic sedative anxiolytic medication ; Prior use insomnia medication exclusionary , patient must medications screen visit study .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>64 Years</maximum_age>
	<verification_date>June 2016</verification_date>
	<keyword>Matricaria</keyword>
	<keyword>Chamomile</keyword>
	<keyword>Herb</keyword>
	<keyword>Insomnia</keyword>
</DOC>